Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank75
3Y CAGR+29.8%
5Y CAGR-18.5%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+29.8%/yr
Annual compound
5Y CAGR
-18.5%/yr
Recent acceleration
Percentile
P75
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.23 | -12.9% |
| 2024 | 1.41 | +33.6% |
| 2023 | 1.06 | +87.7% |
| 2022 | 0.56 | -42.8% |
| 2021 | 0.98 | -71.3% |
| 2020 | 3.43 | +111.4% |
| 2019 | -30.06 | +15.2% |
| 2018 | -35.44 | +16.7% |
| 2017 | -42.56 | - |